JPMorgan Chase & Co’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$108K	Buy	18,717 +16,017	+593%	+$92.3K	﹤0.01%	4760
2025 Q1	$8.86K	Buy	+2,700	New	+$8.86K	﹤0.01%	5465
2024 Q3	–	Sell	-1,892	Closed	-$4.88K	–	6533
2024 Q2	$4.88K	Buy	+1,892	New	+$4.88K	﹤0.01%	5374